# Trazimera

NDC: 0069-0308
Generic name: trastuzumab-qyyp
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210310

FDA application: BLA761081

## Active ingredients

- TRASTUZUMAB: 150 mg/7.15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0308"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0308
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b9c5e894-27d2-4245-a653-df986fed3c56